IBD stock of the day breaks out, lays the groundwork for 2026 acceleration

view original post

Penumbra is Friday’s IBD Stock Of The Day following a strong third-quarter report and a “landmark” study vs. blood thinners.

What’s Driving the Market Sentiment Around Constellation Energy Corp?

Nasdaq 100: Tech Stocks Firm Today as PCE Data Fuels Dovish Fed Forecast for US Stocks

Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.

Enter Your Email Address

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Opt-out any time, we hate spam!